Dear Sir, Please find attachment. Regards, For MRC Agrotech Limited Compliance Officer/ Authorised Signatory
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
MRC Agrotech Ltd filed audited results for Q4 and FY26 with an unqualified (clean) auditor opinion from Choudhary Choudhary & Co. Revenue from operations jumped about 163% YoY to Rs. 85.46 crore (FY25: Rs. 32.45 crore), while profit after tax rose roughly 33% to Rs. 1.17 crore (FY25: Rs. 87.60 lakh). EPS improved to Rs. 0.37 from Rs. 0.04. During the year the company acquired Marsapi Lifesciences Pvt Ltd as a 100% subsidiary via a Rs. 16.85 crore share-swap (issuing about 86.42 lakh shares at Rs. 19.50), increasing equity capital by over 50%. The auditor flagged two Emphasis of Matter items (Marsapi acquisition and a loan-assignment deal with Cicago Commodities) and highlighted Key Audit Matters around low-margin back-to-back trading, with 44.62% of taxable sales concentrated in March 2026 and significant counterparty concentration (two related parties accounting for 53% of purchases and 23% of sales).
Headline growth looks strong but margin quality is weak — profit before tax margin actually compressed to around 1.8% from 3.6%, and operating cash flow fell sharply to Rs. 31 lakh from Rs. 1.96 crore. The share-swap acquisition will dilute existing shareholders by roughly 53% in share count, and the year-end revenue concentration plus low-margin trading raise concerns about the sustainability of the earnings beat.